REGISTERED AND RENEWED
on 23 Jul 2024
Last Applicant/ Owned by
9804 Medical Center Drive
Rockville
MD
20850
Serial Number
85314870 filed on 06th May 2011
Registration Number
4384443 registered on 13th Aug 2013
Correspondent Address
William R. Samuels
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
NAV
Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy
Classification Information
Class [005]
Pharmaceutical Products
Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy
First Use Date in General
01st May 2011
First Use Date in Commerce
01st May 2011
Mark Details
Serial Number
No 85314870
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 101928
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Jul 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 23rd Jul 2024 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| 23rd Jul 2024 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 16th Jul 2024 | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
| 16th Jul 2024 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 10th Jul 2024 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 11th Jan 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 11th Jan 2024 | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
| 13th Jul 2023 | TEAS SECTION 8 & 9 RECEIVED |
| 17th Jun 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |